Haibiao Xie - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Haibiao Xie

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Frontiers in Oncology|November 19, 2019

The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 PatientsKaifang Ma, Baoan Hong, Jingcheng Zhou, et al.

Cancer Discovery|December 8, 2019

TBK1 Is a Synthetic Lethal Target in Cancer with <i>VHL</i> LossLianxin Hu, Haibiao Xie, Xijuan Liu, et al.

Molecular Cell|February 6, 2020

Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL LossXijuan Liu, Jeremy M Simon, Haibiao Xie, et al.

International Journal of Surgery (London, England)|September 22, 2023

SAVE Testis-sparing score: a multicenter retrospective study of a novel predictive tool for quantifying testicular tumorsZhenhua Liu, Junyi Xie, Xiaofeng Gao, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Frontiers in Oncology|November 19, 2019

The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 PatientsKaifang Ma, Baoan Hong, Jingcheng Zhou, et al.

Cancer Discovery|December 8, 2019

TBK1 Is a Synthetic Lethal Target in Cancer with <i>VHL</i> LossLianxin Hu, Haibiao Xie, Xijuan Liu, et al.

Molecular Cell|February 6, 2020

Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL LossXijuan Liu, Jeremy M Simon, Haibiao Xie, et al.

International Journal of Surgery (London, England)|September 22, 2023

SAVE Testis-sparing score: a multicenter retrospective study of a novel predictive tool for quantifying testicular tumorsZhenhua Liu, Junyi Xie, Xiaofeng Gao, et al.

Pageof 4